Douglas Dachille
Director/Board Member at BRIDGEBIO PHARMA, INC.
Net worth: 486 600 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Neil Kumar | M | 45 |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 9 years |
| Charles Homcy | M | 75 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 9 years |
| Peter Zaffino | M | 57 | 7 years | |
| Sabra Purtill | F | 61 | 5 years | |
| Amy Schulman | F | 63 |
Lyndra Therapeutics, Inc.
 Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 9 years |
| Richard Scheller | M | 70 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 6 years |
| Ronald Daniels | M | 64 | 9 years | |
| Mark Gus Alexandridis | M | 66 |
First Principles Capital Management LLC
 First Principles Capital Management LLC Investment ManagersFinance First Principles Capital Management LLC (FPCM) is a registered investment advisor headquartered in New York City. The firm was founded in 2003 by Richard F. Dolan, Douglas A. Dachille and James H. van Epps. In 2015, they were acquired by AIG Capital Corp., a wholly owned subsidiary of American International Group, Inc. (NYSE: AIG). FPCM provides investment advisory and asset management services to affiliated and unaffiliated institutional clients. The firm provides customized separately managed accounts and targeted funds for endowments and foundations, financial institutions, corporations, pension funds, family offices, high net worth individuals, and trusts. | 19 years |
| Andrew Lo | M | 63 | 9 years | |
| Eric Aguiar | M | 62 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 5 years |
| Jessica Ballinger | F | - |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 8 years |
| Ali Satvat | M | 46 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 8 years |
| Brenton Saunders | M | 56 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 4 years |
| Patricia Hurter | M | 60 |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | - |
| Francis McCormick | M | 73 | 9 years | |
| Brian Stephenson | M | 43 | 6 years | |
| Kathleen Carbone | F | 52 | 8 years | |
| Hannah Valantine | M | 72 | 3 years | |
| Carlo Traverso | M | - |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 9 years |
| Andrea Ellis | F | 38 | 3 years | |
| Richard Francis Dolan | M | 65 |
First Principles Capital Management LLC
First Principles Capital Management LLC Investment ManagersFinance First Principles Capital Management LLC (FPCM) is a registered investment advisor headquartered in New York City. The firm was founded in 2003 by Richard F. Dolan, Douglas A. Dachille and James H. van Epps. In 2015, they were acquired by AIG Capital Corp., a wholly owned subsidiary of American International Group, Inc. (NYSE: AIG). FPCM provides investment advisory and asset management services to affiliated and unaffiliated institutional clients. The firm provides customized separately managed accounts and targeted funds for endowments and foundations, financial institutions, corporations, pension funds, family offices, high net worth individuals, and trusts. | 21 years |
| Jonathan Fox | M | 66 | - | |
| Peter Porrino | M | 67 | 5 years | |
| Jennifer Silane | F | - | 3 years | |
| Catherine Reynolds | F | 66 |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | - |
| Randal Scott | M | 66 | 4 years | |
| Robert Langer | M | 74 |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 9 years |
| Jennifer Cook | F | 58 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 5 years |
| Fred Hassan | M | 78 | 3 years | |
| James Cole | M | 55 | 3 years | |
| Ashish Singh | M | - |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 1 years |
| Helene Madonick | F | - |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 1 years |
| Jillian Moo-Young | F | - |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 3 years |
| Jamie Miller | M | - | 6 years | |
| Julia Chapman | F | - |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | - |
| Vikram Bali | M | - | - | |
| Claude Wade | M | 56 | 3 years | |
| Jennifer Waldner | F | - | 5 years | |
| Richard P. Strubel | M | 84 |
The University of Chicago
| 37 years |
| Rohan Nirody | M | - |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | - |
| Uma Sinha | M | 67 | 8 years | |
| Christine Siu | F | 47 | 4 years | |
| Graeme I. Bell | M | - |
The University of Chicago
| 38 years |
| Marilyn Hirsch | F | 56 | 3 years | |
| Jim Momtazee | M | - |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 8 years |
| Zafrira Avnur | M | 73 |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | - |
| Thomas Lillelund | M | - | 4 years | |
| Michelle LeBeau | M | 70 |
The University of Chicago
| 38 years |
| Edward M. Levin | M | - | 5 years | |
| Ramzi Toubassy | M | - | 3 years | |
| Matthew Outten | M | 49 | 5 years | |
| Stephen Roderick Miller | M | - |
First Principles Capital Management LLC
First Principles Capital Management LLC Investment ManagersFinance First Principles Capital Management LLC (FPCM) is a registered investment advisor headquartered in New York City. The firm was founded in 2003 by Richard F. Dolan, Douglas A. Dachille and James H. van Epps. In 2015, they were acquired by AIG Capital Corp., a wholly owned subsidiary of American International Group, Inc. (NYSE: AIG). FPCM provides investment advisory and asset management services to affiliated and unaffiliated institutional clients. The firm provides customized separately managed accounts and targeted funds for endowments and foundations, financial institutions, corporations, pension funds, family offices, high net worth individuals, and trusts. | 20 years |
| Richard Scranton | M | 57 |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 4 years |
| Christine Seidman | M | 71 | - | |
| James Momtazee | M | 52 | 8 years | |
| Eric Michael David | M | 56 | - | |
| Quentin McMillan | M | - | 3 years | |
| Jeff M. Clements | M | - | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian Duperreault | M | 76 | 4 years | |
| Peter Hancock | M | 65 | 7 years | |
| Luciana Fato | F | 57 | - | |
| Michael Frankel | M | 56 |
The University of Chicago
| 9 years |
| Siddhartha Sankaran | M | 46 | 8 years | |
| Jeffrey Hurd | M | 56 | 19 years | |
| Rose Glazer | F | 57 | 7 years | |
| Mark Lyons | M | 67 | 5 years | |
| David Herzog | M | 64 | 16 years | |
| Stephen Bardin | M | 34 | 3 years | |
| Shane Fitzsimons | M | 56 | 4 years | |
| George L. Miles | M | 82 | 12 years | |
| Bill Bergman | M | - |
The University of Chicago
| 3 years |
| Emily Garbaccio | F | - | - | |
| Michael Booth | M | - |
The University of Chicago
| 7 years |
| Jonathan Wismer | M | 52 | 2 years | |
| Thomas Leonardi | M | 70 | - | |
| Catherine Stehman-Breen | M | 61 |
The University of Chicago
| 3 years |
| Carla N. Taylor | F | - |
The University of Chicago
| 6 years |
| Jeremy Feigelson | M | - |
The University of Chicago
| 3 years |
| Becky Li | F | - |
First Principles Capital Management LLC
First Principles Capital Management LLC Investment ManagersFinance First Principles Capital Management LLC (FPCM) is a registered investment advisor headquartered in New York City. The firm was founded in 2003 by Richard F. Dolan, Douglas A. Dachille and James H. van Epps. In 2015, they were acquired by AIG Capital Corp., a wholly owned subsidiary of American International Group, Inc. (NYSE: AIG). FPCM provides investment advisory and asset management services to affiliated and unaffiliated institutional clients. The firm provides customized separately managed accounts and targeted funds for endowments and foundations, financial institutions, corporations, pension funds, family offices, high net worth individuals, and trusts. | 17 years |
| Donnalee DeMaio | F | 65 | 5 years | |
| Elizabeth A. Werner | F | - | 8 years | |
| Chang-Jin Moon | M | 71 |
The University of Chicago
| 2 years |
| Ronald Rittenmeyer | M | 76 | 9 years | |
| Mark Phelan | M | 55 |
The University of Chicago
| 3 years |
| Theresa M. Stone | F | 79 | 6 years | |
| Terri Vaughan Vaughan | M | 67 | 5 years | |
| Richard C. Wirthlin | M | - |
The University of Chicago
| 3 years |
| Samuel Merksamer | M | 43 | 2 years | |
| Peter Ryerson Fisher | M | 67 | 4 years | |
| Jeffrey Gulcher | M | - |
The University of Chicago
| 7 years |
| Henry Stephen Miller | M | 78 | 11 years | |
| Spiro Voulgaris | M | - |
The University of Chicago
| 9 years |
| Igal Litovsky | M | - |
The University of Chicago
| 4 years |
| Suzanne Johnson | F | 66 | 12 years | |
| Luis Alberto Mañas Antón | M | 65 |
The University of Chicago
| 4 years |
| Thomas A. Russo | M | 80 | 6 years | |
| Tom Motamed | M | 75 | 4 years | |
| Jim Sanderson | M | - |
The University of Chicago
| 4 years |
| David Abramson | M | - |
The University of Chicago
| 2 years |
| Daniel J. Young | M | - |
The University of Chicago
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Douglas Dachille
- Personal Network
